How to buy Akoya Biosciences stock (Akoya Biosciences)

Akoya Biosciences is a medical instruments & supplies business based in the US. Akoya Biosciences shares (AKYA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.85 – a decrease of 0.7% over the previous week. Akoya Biosciences employs 330 staff and has a trailing 12-month revenue of around $93.2 million.

Our top picks for where to buy Akoya Biosciences stock

Buy Akoya Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Akoya Biosciences stock price (NASDAQ: AKYA)

Use our graph to track the performance of AKYA stocks over time.

Akoya Biosciences shares at a glance

• Key figures

Information last updated 2024-10-25.

Latest market close	$2.85
52-week range	$1.88 - $6.31
50-day moving average more info button	$2.73
200-day moving average more info button	$3.50
Wall St. target price	$5.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.17

Is it a good time to buy Akoya Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Akoya Biosciences price performance over time

Historical closes compared with the close of $2.9 from 2024-10-28

1 week (2024-10-22)	1.05%
1 month (2024-09-30)	6.62%
3 months (2024-07-30)	17.41%
6 months (2024-04-30)	-24.08%

1 year (2023-10-30)	-14.71%
2 years (2022-10-28)	-78.79%
3 years (2021-10-29)	13.25
5 years (2019-10-26)	N/A

Akoya Biosciences financials

Revenue TTM	$93.2 million
Gross profit TTM	$43.4 million
Return on assets TTM	-18.09%
Return on equity TTM	-128.2%
Profit margin	-64.74%
Book value	$0.45
Market Capitalization more info button	$142.1 million

TTM: trailing 12 months

Akoya Biosciences share dividends

We're not expecting Akoya Biosciences to pay a dividend over the next 12 months.

You may also wish to consider:

Akoya Biosciences share price volatility

Over the last 12 months, Akoya Biosciences's shares have ranged in value from as little as $1.88 up to $6.31. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akoya Biosciences's is 1.364. This would suggest that Akoya Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

To put Akoya Biosciences's beta into context you can compare it against those of similar companies.

• Neurocrine Biosciences (NBIX.US): 0.364
• Geron Corporation (GERN.US): 0.501
• Rigel Pharmaceuticals (RIGL.US): 0.935

Akoya Biosciences overview

Akoya Biosciences, Inc. , a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Frequently asked questions

null
What percentage of Akoya Biosciences is owned by insiders or institutions?
Currently 11.091% of Akoya Biosciences shares are held by insiders and 66.247% by institutions. How many people work for Akoya Biosciences?
Latest data suggests 330 work at Akoya Biosciences. When does the fiscal year end for Akoya Biosciences?
Akoya Biosciences's fiscal year ends in December. Where is Akoya Biosciences based?
Akoya Biosciences's address is: 100 Campus Drive, Marlborough, MA, United States, 01752 What is Akoya Biosciences's ISIN number?
Akoya Biosciences's international securities identification number is: US00974H1041